EP4233849A1 — Pharmaceutical composition comprising pomalidomide
Assigned to KRKA dd · Expires 2023-08-30 · 3y expired
What this patent protects
The invention pertains to pharmaceutical compositions and pharmaceutical dosage forms containing Pomalidomide, optionally in combination with one or more other active pharmaceutical substances, and low-substituted hydroxypropyl cellulose. The pharmaceutical compositions and pharm…
USPTO Abstract
The invention pertains to pharmaceutical compositions and pharmaceutical dosage forms containing Pomalidomide, optionally in combination with one or more other active pharmaceutical substances, and low-substituted hydroxypropyl cellulose. The pharmaceutical compositions and pharmaceutical dosage forms are physically and chemically stable and are easy to manufacture. The pharmaceutical compositions and pharmaceutical dosage are provided in a solid form suitable for oral administration. The invention further provides a methods for making the pharmaceutical compositions and pharmaceutical dosage forms.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.